Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 5, 2005, Pages 1291-1298

  Buyyounouski, Mark K ^a   Hanlon, Alexandra L ^a   Horwitz, Eric M ^a   Uzzo, Robert G ^a   Pollack, Alan ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Prostate specific antigen; Prostatic neoplasm; Radiotherapy; Treatment failure

Indexed keywords

BIOCHEMISTRY; HORMONES; ONCOLOGY; PATIENT MONITORING; RADIOTHERAPY; TUMORS;

ANDROGEN DEPRIVATION (AD); BIOCHEMICAL FAILURES (BF); NONBIOCHEMICAL FAILURES (NBF); PROSTRATE-SPECIFIC ANTIGEN (PSA);

ANTIGENS;

ANDROGEN; BICALUTAMIDE; FLUTAMIDE; GOSERELIN; LEUPRORELIN; NILUTAMIDE; PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CONSENSUS; CONTROLLED STUDY; FOLLOW UP; HUMAN; KINETICS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MEDICAL SOCIETY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 16344394286     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.08.034     Document Type: Article

References (30)

1. M.V. Pilepich, K. Winter, M.J. John Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Int J Radiat Oncol Biol Phys 50 2001 1243 1252
2. M.V. Pilepich, K. Winter, C. Lawton Androgen suppression adjuvant to radiotherapy in carcinoma of the prostate. Long-term results of phase III RTOG study 85-31 Int J Radiat Oncol Biol Phys 57 2003 S172 S173
3. M. Bolla, L. Collette, D. Gonzalez Long term results of immediate adjuvant hormonal therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy. A phase III EORTC study Int J Radiat Oncol Biol Phys 45 1999 147
4. T. Granfors, H. Modig, J.-E. Damber Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement A prospective randomized study J Urol 159 1998 2030 2034
5. H.C. Ruckle, J.E. Oesterling Prostate-specific antigen and androgen deprivation therapy World J Urol 11 1993 227 232
6. G.K. Zagars, M.E. Sands, A. Pollack Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer Prognostic variables and outcome J Urol 151 1994 1330 1333
7. A. Pollack, A.L. Hanlon, B. Movsas Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy Int J Radiat Oncol Biol Phys 57 2003 19 23
8. E.M. Horwitz, F.A. Vicini, E.L. Ziaja Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control Int J Radiat Oncol Biol Phys 36 1996 565 571
9. G.E. Hanks, B.W. Corn, W.R. Lee External beam irradiation of prostate cancer. Conformal treatment techniques and outcomes for the 1990s Cancer 75 1995 1972 1977
10. I.D. Kaplan, R.S. Cox, M.A. Bagshaw Prostate specific antigen after external beam radiotherapy for prostatic cancer Followup J Urol 149 1993 519 522
11. A.L. Zietman, J.J. Coen, K.C. Dallow The treatment of prostate cancer by conventional radiation therapy An analysis of long-term outcome Int J Radiat Oncol Biol Phys 32 1995 287 292
12. M.B. Gretzer, B. Trock, M. Han A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiology and Oncology criteria J Urol 167 2002 68
13. American Society for Therapeutic Radiology and Oncology Consensus Panel Consensus statement Guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1997 1035 1041
14. A.M. Slivjak, W.H. Pinover, A.L. Hanlon The ASTRO Consensus Guidelines definition of bNED failure is an inappropriate endpoint for prostate cancer patients receiving conformal radiation therapy and androgen deprivation (CRT + AD) Int J Radiat Oncol Biol Phys 42 1998 176
15. A.L. Hanlon, G.E. Hanks Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness Int J Radiat Oncol Biol Phys 46 2000 559 566
16. R.D. Ennis, B.K. Malyszko, D.F. Heitjan Changes in biochemical disease-free survival rates as a result of adoption of the Consensus Conference definition in patients with clinically localized prostate cancer treated with external-beam radiotherapy Int J Radiat Oncol Biol Phys 41 1998 511 517
17. E.M. Horwitz, F.A. Vicini, E.L. Ziaja The correlation between the ASTRO consensus panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation Int J Radiat Oncol Biol Phys 41 1998 267 272
18. F.A. Vicini, L.L. Kestin, A.A. Martinez The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer Int J Radiat Oncol Biol Phys 45 1999 553 561
19. American Joint Committee on Cancer Prostate F.L. Greene D.L. Page I.D. Fleming AJCC cancer staging manual 2002 Lippincott Raven Publishers Philadelphia 309 316
20. G.E. Hanks, T.F. Pajak, A. Porter Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate The Radiation Therapy Oncology Group Protocol 92-02 J Clin Oncol 21 2003 3972 3978
21. E.M. Horwitz, A.L. Hanlon, W.H. Pinover, P.R. Anderson, G.E. Hanks Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques Cancer 92 2001 1281 1287
22. A.F. Monti, A. Ostinelli, M. Frigerio An ICRU 50 radiotherapy treatment chart Radiother Oncol 35 1995 145 150
23. W. Cleveland, S.J. Devlin Locally weighted regression An approach to regression analysis by local fitting J Am Stat Assoc 83 1988 596 610
24. M.W. Kattan, P.A. Fearn, S. Leibel The definition of biochemical failure in patients treated with definitive radiotherapy Int J Radiat Oncol Biol Phys 48 2000 1469 1474
25. J.M. Taylor, K.A. Griffith, H.M. Sandler Definitions of biochemical failure in prostate cancer following radiation therapy Int J Radiat Oncol Biol Phys 50 2001 1212 1219
26. T. Pickles, C. Kim-Sing, W.J. Morris Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias Int J Radiat Oncol Biol Phys 57 2003 11 18
27. R. Takamiya, V. Weinberg, C.D. Young A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 56 2003 1073 1078
28. R.T. Vollmer, S. Egawa, S. Kuwao The dynamics of prostate specific antigen during watchful waiting of prostate carcinoma A study of 94 Japanese men Cancer 94 2002 1692 1698
29. G.K. Zagars, A. Pollack The fall and rise of prostate-specific antigen. Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer Cancer 72 1993 832 842
30. L. Austen, J. Crook, M. McLean PSA Kinetics following brachytherapy treatment with I-125 seeds in early stage prostate cancer 2002 The annual meeting of the Canadian Association of Radiation Oncologists (CARO-ACRO). Toronto, Canada;